Allogene Therapeutics Market Cap

Allogene Therapeutics has a market cap or net worth of $516.88 million as of March 6, 2026. Its market cap has increased by 9.32% in one year.

Market Cap

516.88M

Enterprise Value

349.83M

1-Year Change

9.32%

Ranking

#3000

Market Cap Chart

Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $516.88M, a decrease of -82.06%. That is a compound annual growth rate of -20.70%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	516.88M	67.88%
Dec 31, 2025	307.88M	-31.06%
Dec 31, 2024	446.60M	-17.32%
Dec 29, 2023	540.17M	-40.45%
Dec 30, 2022	907.08M	-57.34%
Dec 31, 2021	2.13B	-39.95%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
uniQure	589.28M
Larimar Therapeutics	585.30M
Design Therapeutics	584.45M
MeiraGTx Holdings	571.49M
Forte Biosciences	558.12M
Fulcrum Therapeutics	542.79M
Verastem	537.55M
Rigel Pharmaceuticals	530.18M

Market Cap Rankings